Emerging in the field of obesity therapy, retatrutide is a distinct strategy. Unlike many existing medications, retatrutide operates as a dual agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and https://jayybeu969195.bloggin-ads.com/61751935/the-innovative-retatrutide-a-glp-gip-binding-site-agonist